BindingDB logo
myBDB logout

null

SMILES: CCCS(=O)(=O)N[C@H]1C[C@@H](C1)N(C)c1ncnc2[nH]ccc12

InChI Key: InChIKey=IUEWXNHSKRWHDY-XYPYZODXSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 50243847   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Non-receptor tyrosine-protein kinase TYK2


(Homo sapiens (Human))
BDBM50243847
PNG
(CHEMBL4101725)
Show SMILES CCCS(=O)(=O)N[C@H]1C[C@@H](C1)N(C)c1ncnc2[nH]ccc12 |r,wU:7.6,wD:9.11,(18.67,-11.52,;17.33,-12.28,;16,-11.51,;14.66,-12.28,;15.42,-13.61,;13.89,-13.61,;13.33,-11.52,;12,-12.29,;11.61,-13.78,;10.12,-13.4,;10.51,-11.9,;8.79,-14.17,;7.45,-13.4,;8.79,-15.71,;7.46,-16.48,;7.46,-18.02,;8.8,-18.8,;10.14,-18.02,;11.61,-18.48,;12.51,-17.23,;11.59,-15.99,;10.13,-16.47,)|
Show InChI InChI=1S/C14H21N5O2S/c1-3-6-22(20,21)18-10-7-11(8-10)19(2)14-12-4-5-15-13(12)16-9-17-14/h4-5,9-11,18H,3,6-8H2,1-2H3,(H,15,16,17)/t10-,11-
PDB

KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
Purchase

CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a>2.00E+5n/an/an/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Inhibition of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor


J Med Chem 61: 1130-1152 (2018)


Article DOI: 10.1021/acs.jmedchem.7b01598
BindingDB Entry DOI: 10.7270/Q2D79DTW
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM50243847
PNG
(CHEMBL4101725)
Show SMILES CCCS(=O)(=O)N[C@H]1C[C@@H](C1)N(C)c1ncnc2[nH]ccc12 |r,wU:7.6,wD:9.11,(18.67,-11.52,;17.33,-12.28,;16,-11.51,;14.66,-12.28,;15.42,-13.61,;13.89,-13.61,;13.33,-11.52,;12,-12.29,;11.61,-13.78,;10.12,-13.4,;10.51,-11.9,;8.79,-14.17,;7.45,-13.4,;8.79,-15.71,;7.46,-16.48,;7.46,-18.02,;8.8,-18.8,;10.14,-18.02,;11.61,-18.48,;12.51,-17.23,;11.59,-15.99,;10.13,-16.47,)|
Show InChI InChI=1S/C14H21N5O2S/c1-3-6-22(20,21)18-10-7-11(8-10)19(2)14-12-4-5-15-13(12)16-9-17-14/h4-5,9-11,18H,3,6-8H2,1-2H3,(H,15,16,17)/t10-,11-
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
Purchase

CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a>9.30E+3n/an/an/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Inhibition of cytochrome P450 19A1


J Med Chem 61: 1130-1152 (2018)


Article DOI: 10.1021/acs.jmedchem.7b01598
BindingDB Entry DOI: 10.7270/Q2D79DTW
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK1


(Homo sapiens (Human))
BDBM50243847
PNG
(CHEMBL4101725)
Show SMILES CCCS(=O)(=O)N[C@H]1C[C@@H](C1)N(C)c1ncnc2[nH]ccc12 |r,wU:7.6,wD:9.11,(18.67,-11.52,;17.33,-12.28,;16,-11.51,;14.66,-12.28,;15.42,-13.61,;13.89,-13.61,;13.33,-11.52,;12,-12.29,;11.61,-13.78,;10.12,-13.4,;10.51,-11.9,;8.79,-14.17,;7.45,-13.4,;8.79,-15.71,;7.46,-16.48,;7.46,-18.02,;8.8,-18.8,;10.14,-18.02,;11.61,-18.48,;12.51,-17.23,;11.59,-15.99,;10.13,-16.47,)|
Show InChI InChI=1S/C14H21N5O2S/c1-3-6-22(20,21)18-10-7-11(8-10)19(2)14-12-4-5-15-13(12)16-9-17-14/h4-5,9-11,18H,3,6-8H2,1-2H3,(H,15,16,17)/t10-,11-
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
Purchase

CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 572n/an/an/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant human JAK1 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay


J Med Chem 61: 1130-1152 (2018)


Article DOI: 10.1021/acs.jmedchem.7b01598
BindingDB Entry DOI: 10.7270/Q2D79DTW
More data for this
Ligand-Target Pair
Non-receptor tyrosine-protein kinase TYK2/Tyrosine-protein kinase JAK1


(Homo sapiens (Human))
BDBM50243847
PNG
(CHEMBL4101725)
Show SMILES CCCS(=O)(=O)N[C@H]1C[C@@H](C1)N(C)c1ncnc2[nH]ccc12 |r,wU:7.6,wD:9.11,(18.67,-11.52,;17.33,-12.28,;16,-11.51,;14.66,-12.28,;15.42,-13.61,;13.89,-13.61,;13.33,-11.52,;12,-12.29,;11.61,-13.78,;10.12,-13.4,;10.51,-11.9,;8.79,-14.17,;7.45,-13.4,;8.79,-15.71,;7.46,-16.48,;7.46,-18.02,;8.8,-18.8,;10.14,-18.02,;11.61,-18.48,;12.51,-17.23,;11.59,-15.99,;10.13,-16.47,)|
Show InChI InChI=1S/C14H21N5O2S/c1-3-6-22(20,21)18-10-7-11(8-10)19(2)14-12-4-5-15-13(12)16-9-17-14/h4-5,9-11,18H,3,6-8H2,1-2H3,(H,15,16,17)/t10-,11-
PDB

UniProtKB/SwissProt

antibodypedia
antibodypedia
GoogleScholar
AffyNet 
Purchase

CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 6.45E+3n/an/an/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Inhibition of JAK1/TYK2 in human whole blood assessed as reduction in IFNalpha induced STAT3 phosphorylation preincubated for 45 mins followed by IFN...


J Med Chem 61: 1130-1152 (2018)


Article DOI: 10.1021/acs.jmedchem.7b01598
BindingDB Entry DOI: 10.7270/Q2D79DTW
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM50243847
PNG
(CHEMBL4101725)
Show SMILES CCCS(=O)(=O)N[C@H]1C[C@@H](C1)N(C)c1ncnc2[nH]ccc12 |r,wU:7.6,wD:9.11,(18.67,-11.52,;17.33,-12.28,;16,-11.51,;14.66,-12.28,;15.42,-13.61,;13.89,-13.61,;13.33,-11.52,;12,-12.29,;11.61,-13.78,;10.12,-13.4,;10.51,-11.9,;8.79,-14.17,;7.45,-13.4,;8.79,-15.71,;7.46,-16.48,;7.46,-18.02,;8.8,-18.8,;10.14,-18.02,;11.61,-18.48,;12.51,-17.23,;11.59,-15.99,;10.13,-16.47,)|
Show InChI InChI=1S/C14H21N5O2S/c1-3-6-22(20,21)18-10-7-11(8-10)19(2)14-12-4-5-15-13(12)16-9-17-14/h4-5,9-11,18H,3,6-8H2,1-2H3,(H,15,16,17)/t10-,11-
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
Purchase

CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a>2.00E+4n/an/an/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Inhibition of JAK2 in CD34+ human whole blood assessed as reduction in EOP induced STAT5 phosphorylation preincubated for 45 mins followed by EOP add...


J Med Chem 61: 1130-1152 (2018)


Article DOI: 10.1021/acs.jmedchem.7b01598
BindingDB Entry DOI: 10.7270/Q2D79DTW
More data for this
Ligand-Target Pair